JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

RNA-LNP

M2001 DMG-PEG 2000
1 Citation

Summary: PEG modified phospholipids for liposome delivery

Soluble in DMSO
M2005 DMG-PEG2000-MAL

Summary: Maleimide-PEG derivatives, used for liposomal delivery

≥34.4 mg/mL
M2006 DMG-PEG2000-NH₂

Summary: NH₂-PEG derivatives, used for liposomal delivery

≥51.6 mg/mL
M2004 DMG-PEG2000-NHS

Summary: NHS-PEG derivatives, used for liposomal delivery

≥49.7 mg/mL
A8791 D-Lin-MC3-DMA
4 Citation

Summary: An effective, ionizable cationic liposome for in vivo delivery of siRNA, also suitable for preparing nanoparticles for mRNA drug delivery.
B1702 Cholesterol
3 Citation

Summary: The principal sterol to build and maintain membranes
C1042 SM-102
5 Citation

insoluble in DMSO; ≥175.8 mg/mL
B8595 ALC-0315

Summary: ALC-0315 is an ionizable amino lipid that can be combined with other lipids to form lipid nanoparticles (LNP). LNP containing ALC-0315 can be utilized for the delivery of mRNA vaccines.

≥59.3 mg/mL
B8596 ALC-0159
1 Citation

Summary: ALC-0159 is a lipid excipient. ALC-0159-containing formulation have been used to develop lipid nanoparticles (LNPs) for the delivery of mRNA-based vaccines.

≥39.4 mg/mL
C4002 1,2-Dipalmitoyl-sn-glycero-3-PC

Summary: Liposomes assist phospholipids

insoluble in DMSO; ≥51.6 mg/mL